WILMINGTON, Mass., Dec. 22, 2025 (GLOBE NEWSWIRE) -- UniFirst Corporation (the “Company” or “UniFirst”) (NYSE: UNF) today confirmed it received an unsolicited, non-binding proposal from Cintas Corporation (“Cintas”) (NASDAQ: CTAS) to acquire all the outstanding UniFirst common and Class B shares for $275.00 per share in cash on December 12, 2025. Upon receipt of Cintas’ proposal, the UniFirst Board of Directors, engaged independent financial and legal advisors. Consistent with its fiduciary duties and in co ...

Core Viewpoint - Legence Corp. is conducting a secondary underwritten public offering of 7,000,000 shares of its Class A common stock, with an additional option for underwriters to purchase up to 1,050,000 shares [1] Company Overview - Legence is a leading provider of engineering, consulting, installation, and maintenance services for mission-critical systems in buildings, specializing in HVAC, process piping, and other mechanical, electrical, and plumbing (MEP) systems [5] - The company enhances energy efficiency, reliability, and sustainability in both new and existing facilities, serving over 60% of the Nasdaq-100 Index among its clients [5] Offering Details - The offering will not involve Legence selling any shares or receiving proceeds; instead, it is solely for the selling stockholders affiliated with Blackstone Inc. [2] - Goldman Sachs & Co. LLC and Jefferies are the joint lead book-running managers for the offering, with Blackstone Capital Markets acting as a co-manager [2] - The shares are being offered under a Registration Statement filed with the SEC on December 9, 2025, which has not yet become effective [4]

Core Viewpoint - Alkermes plc has reached an agreement to acquire Avadel Pharmaceuticals plc, with the transaction structured as a scheme of arrangement under Irish law [1][8]. Group 1: Proposed Transaction Details - The acquisition involves Alkermes acquiring the entire issued and to be issued ordinary share capital of Avadel [1]. - The Proposed Transaction will be implemented through a scheme of arrangement under Chapter 1 of Part 9 of the Irish Companies Act 2014 [1][8]. - A joint letter detailing the proposal has been sent to Avadel Equity Award Holders and ESPP Participants [2]. Group 2: Company Profiles - Alkermes is a global biopharmaceutical company focused on developing innovative medicines for neurological disorders, with a portfolio that includes treatments for alcohol and opioid dependence, schizophrenia, and bipolar I disorder [4]. - Avadel Pharmaceuticals specializes in transforming medicines to improve patient outcomes, with its commercial product LUMRYZ™ approved for treating narcolepsy [5][6]. Group 3: Additional Information - The Rule 15 Proposal is available for inspection on both Avadel's and Alkermes' websites [3]. - Avadel filed a definitive proxy statement with the U.S. Securities and Exchange Commission on December 3, 2025, which includes important information regarding the Proposed Transaction [9][11].

Core Insights - SEI has completed the first stage of its strategic investment in Stratos Wealth Holdings, acquiring the U.S.-based Stratos business for approximately $441 million, which represents about 81% of the total transaction value [1] - The partnership aims to enhance the wealth management ecosystem by combining SEI's strengths in advice, asset management, and administration with Stratos' independent advisory platform [1] - Stratos operates a national network of over 350 financial advisors across 29 states, advising approximately $38 billion in client assets [1] Company Overview - SEI is a leading global provider of financial technology, operations, and asset management services, managing approximately $1.8 trillion in assets as of September 30, 2025 [1] - Stratos Wealth Holdings supports independent financial advisors through flexible affiliation models and provides practice management consulting, operations, IT, and compliance services [1] Transaction Details - SEI will pay a total cash consideration of approximately $544 million for 57.5% of the equity of SEI-Eclipse Holding Company, with certain legacy Stratos equity holders retaining 42.5% [1] - The second stage of the transaction, involving the purchase of the Mexico-based NSC business, is expected to close in 2026, subject to regulatory approval [1]

Core Points - Lennar Corporation announced that its Exchange Offer for Millrose Properties, Inc. Class A stock was oversubscribed, with 91,972,752 shares of Lennar Class A common stock validly tendered [1][3] - The final exchange ratio was set at 4.1367 shares of Millrose Class A common stock for each share of Lennar Class A common stock tendered [2][15] - Due to the oversubscription, only a portion of the tendered shares will be accepted on a pro rata basis, with approximately 7.97% of the tendered shares expected to be exchanged [4][5] Exchange Offer Details - The Exchange Offer expired on November 21, 2025, with a guaranteed delivery period extending until November 25, 2025 [1] - Stockholders who tendered fewer than 100 shares will not be subject to proration [4] - The total number of shares accepted in the Exchange Offer was 8,049,596 [7] Financial Implications - Shares of Lennar Class A common stock that were not accepted will be returned to stockholders in book-entry form [6] - The Exchange Agent will credit shares of Millrose Class A common stock to accounts of tendering stockholders whose shares were accepted [6] - Checks for fractional shares will be delivered after aggregation and sale in the open market [6]

Core Points - GRAIL, Inc. has entered into a securities purchase agreement for a private placement expected to yield gross proceeds of approximately $325.0 million before expenses [1][2][4] - The private placement involves participation from both new and existing institutional investors, including notable firms such as Deep Track Capital and Farallon Capital Management [2] - GRAIL plans to utilize the net proceeds for commercial activities, reimbursement efforts, working capital, and general corporate purposes [2][3] Financial Details - GRAIL will issue and sell 4,639,543 shares of common stock at a price of $70.05 per share, with the private placement expected to close on October 21, 2025, pending customary closing conditions [4][5] - The company anticipates that its cash, cash equivalents, and investments, along with the expected net proceeds from this private placement, will fund operations into 2030 [3] Regulatory Information - The securities sold in this private placement have not been registered under the Securities Act of 1933 and may not be offered or sold in the U.S. without an effective registration statement or applicable exemption [6] - GRAIL has granted registration rights to purchasers and will file a registration statement with the SEC for the resale of the shares [6] Company Overview - GRAIL is focused on early cancer detection using next-generation sequencing and advanced machine learning technologies, aiming to alleviate the global burden of cancer [8] - The company is headquartered in Menlo Park, CA, with additional locations in Washington, D.C., North Carolina, and the United Kingdom [8]

Core Viewpoint - Firefly Aerospace has announced the acquisition of SciTec, Inc. for approximately $855 million, enhancing its capabilities in defense and space technology [3][4]. Company Overview - Firefly Aerospace is a leading space and defense technology company, known for its responsive launch and mission services [3][10]. - SciTec, Inc. specializes in advanced national security technologies and generated revenues of approximately $164 million for the twelve-month period ending June 30, 2025 [5][6]. Acquisition Details - The acquisition will be financed through $300 million in cash and $555 million in Firefly shares priced at $50 per share [3]. - The deal is expected to close by the end of 2025, pending regulatory approvals [7]. Strategic Benefits - The acquisition will enhance Firefly's ability to support defense missions and provide operational advantages through SciTec's software and big data processing capabilities [4]. - SciTec's core capabilities include missile warning, tracking, intelligence, surveillance, reconnaissance, and autonomous command and control, which will complement Firefly's existing services [4][5]. Contractual Highlights - SciTec was awarded a $259 million contract by the U.S. Space Force to enhance the Future Operational Resilient Ground Evolution (FORGE) framework [5]. - The contract aims to strengthen the Space Force's missile warning and tracking mission [5]. Leadership and Integration - SciTec will operate as a subsidiary of Firefly under its current business model, with Jim Lisowski continuing as CEO [7]. - Both companies share a similar culture focused on innovation and mission-critical solutions [6].

Core Viewpoint - OpenText Corporation has reached a definitive agreement to divest its on-premise solution eDOCS, part of its Analytics portfolio, to NetDocuments for US$163 million in cash, aligning with its strategy to focus on core business areas and reduce debt [1][2][3]. Summary by Sections Transaction Details - The divested business, eDOCS, is part of OpenText's Analytics product group, primarily serving legal professionals, and generated approximately US$30 million in annual revenue for the fiscal year ending June 30, 2025 [2]. - The transaction is expected to close by early 2026, pending customary approvals and closing conditions [4]. Strategic Implications - The divestiture supports OpenText's strategy to enhance shareholder value by rationalizing non-core assets and focusing on secure information management for AI, which is seen as a driver for future revenue growth [3]. - The proceeds from the sale will be utilized to reduce the company's outstanding debt, reinforcing its capital allocation framework [2][3]. Transition and Integration - Under the agreement, all software, customer contracts, associated services, and employees related to eDOCS will be integrated into NetDocuments, ensuring a seamless transition for users [4].

Core Viewpoint - Comscore Inc. has announced a recapitalization agreement aimed at simplifying its balance sheet, reducing dividend obligations, and strengthening its market position, which has led to a significant increase in its stock price [1][7]. Recapitalization Agreement - The recapitalization involves swapping Series B preferred stock for common shares and new Series C preferred shares that carry no dividend, effectively removing over $18 million in annual obligations [3]. - The agreement includes the exchange of approximately $80 million in Series B preferred shares for common stock at a price of $8.11 per share, and $183.7 million will convert into Series C preferred stock priced at $14.50 per share [4]. Financial Impact - The new Series C shares can convert into common stock at a one-to-one ratio and eliminate the right to a $47 million special dividend, enhancing Comscore's financial flexibility [4][5]. - If approved, the recapitalization would result in the issuance of over 22 million shares on an as-converted basis, giving preferred shareholders nearly 82% of equity [7]. Governance Changes - The agreement will reduce the board size from 10 members to 7 and limit preferred shareholders' director rights while maintaining independent oversight [6]. - Voting caps and conversion limits are designed to balance governance within the new structure [6]. Market Reaction - Following the announcement, Comscore's shares rose by 29.25%, trading at $7.910 in premarket [7].

Core Viewpoint - Mirion has entered into a definitive agreement to acquire Paragon Energy Solutions for approximately $585 million in cash, enhancing its capabilities in the nuclear power industry and expanding its global reach [1][2]. Company Overview - Mirion is a global provider of radiation detection, measurement, analysis, and monitoring solutions, serving various end markets including nuclear, medical, defense, and research [13]. - Paragon Energy Solutions specializes in engineered solutions for the nuclear power industry, with a strong portfolio that includes critical nuclear systems and over 20,000 proprietary parts [3][13]. Financial Aspects - The acquisition price of $585 million represents approximately 18 times Paragon's expected Adjusted EBITDA for 2026, which is projected to be around $150 million with margins of 20% - 22% [2][4]. - The acquisition is expected to be accretive to diluted EPS in the first full year post-close and generate annualized commercial and cost synergies of $10 million [4][5]. Strategic Implications - The transaction is anticipated to broaden Mirion's offerings for nuclear power customers, including small modular reactors (SMRs), and strengthen the global supply chain for nuclear operations [2][4]. - Mirion's Chairman emphasized that the complementary capabilities of both companies will enhance customer experience and support the growing needs of the nuclear power sector [2]. Operational Details - The acquisition is supported by a fully committed bridge facility, with permanent financing expected to maintain a pro forma net debt to Adjusted EBITDA ratio of approximately 3.5x or lower [5]. - The transaction is expected to close before the end of 2025, subject to customary closing conditions and regulatory review [5]. Market Guidance - Mirion has revised its organic revenue growth guidance for the fiscal year ending December 31, 2025, now expecting growth of approximately 4.5% – 6.0%, down from a previous estimate of 5.0% – 7.0% [7][8].